Ironwood Pharma's total assets for Q2 2025 were $342.95M, an increase of 4.81% from the previous quarter. IRWD total liabilities were $651.11M for the fiscal quarter, a -1.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.